Neil Mahapatra
Managing Partner @ Kingsley Capital Partners
London, United Kingdom
Neil Mahapatra is a seed investor at Kingsley Capital Partners in London focused on Medical and Cannabis. Neil Mahapatra is the Founder and Managing Partner of Kingsley Capital Partners. He Previously worked at J. Rothschild Capital Management as a Private Equity Executive. Neil Mahapatra attended Harvard Business School.
- Total investments:
- 5
- Last investment:
- Lead investor:
- 20%
Last updated:
For AI agents: llms.txt
Industries Neil Mahapatra invests in
Stages Neil Mahapatra invests in
Countries Neil Mahapatra invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Medical 2 (40%)
- Cannabis 2 (40%)
- Wireless 1 (20%)
- Health Care 1 (20%)
- Biotechnology 1 (20%)
Stage
- Seed 3 (60%)
- Post-IPO Debt 1 (20%)
- Venture - Series Unknown 1 (20%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Oxford Cannabinoid Technologies
|
Oxford Cannabinoid Technologies is a biopharmaceutical company established to combine cannabinoid medicine with world class scientific research and drug development. OCT brings together some of the world’s best medical researchers to develop new therapies for diseases with high unmet medical need. | $713.8K / Post-IPO Debt / Feb 02, 2024 | |
|
Spring Fibre
|
Seed / Sep 25, 2019 | ||
Atlas Tower Group
|
Atlas Tower Group is a wireless infrastructure solution provider specialized in designing towers and rooftops that are 5G ready. | Seed / Nov 01, 2018 | |
Equinox International
|
Equinox is a cannabis company focused on developing pharmaceutical quality products. | Seed / Jan 03, 2018 | |
|
Oxford Cannabinoid Technologies
|
Oxford Cannabinoid Technologies is a biopharmaceutical company established to combine cannabinoid medicine with world class scientific research and drug development. OCT brings together some of the world’s best medical researchers to develop new therapies for diseases with high unmet medical need. | $12.3M / Venture - Series Unknown / Mar 16, 2017 |
Co-Investors
Kingsley Capital Partners Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Neil Mahapatra
Managing Partner
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Neil Mahapatra invest in?
Neil Mahapatra invests primarily in Medical, Cannabis and Wireless startups, most often at Seed and Post-IPO Debt stage. Most of the 5 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Neil Mahapatra?
Public channels for Neil Mahapatra include LinkedIn and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Neil Mahapatra last invest?
The most recent investment recorded for Neil Mahapatra closed in Feb 2024. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
